First in Class Ferroptosis Inhibitors: For Preventative Treatment of Delayed Graft Function in Kidney Transplantation and other Ferroptosis-related indications
Innovative approach to treat ALS using a novel small molecule target
Small molecule and enzymatic approaches to revert aberrant phase transitions in neurological disorders
Advancing a non-hallucinogenic psychedelic drug combination
D2B3 - Drug Delivery across the Blood Brain Barrier
Targeted Vimentin Inhibitor to Prevent Lung Cancer Progression and Metastasis
NuFoll: Programming skin cells to regrow natural hair
Novel Mechanism for Treating Cutaneous Lupus: Topical Non-Steroid Treatment
First-in-class small molecules for cancer cachexia
Developing therapeutics for novel targets controlling oncogene amplification
